The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 101-59-87
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2024
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kuzmina U.Sh.

Bashkir State Medical University;
Institute of Biochemistry and Genetics — Subdivision of the Ufa Federal Research Center

Tukhvatullin A.V.

Institute of Biochemistry and Genetics — Subdivision of the Ufa Federal Research Center

Lyutov O.V.

Bashkir State Medical University

Talipova I.D.

Bashkir State Medical University

Zakirova E.N.

Bashkir State Medical University

Rakhmatullin A.R.

Bashkir State Medical University

Kutlubaev M.A.

Bashkir State Medical University

Bakhtiyarova K.Z.

Bashkir State Medical University

A case of COVID-associated encephalopathy in a patient with multiple sclerosis

Authors:

Kuzmina U.Sh., Tukhvatullin A.V., Lyutov O.V., Talipova I.D., Zakirova E.N., Rakhmatullin A.R., Kutlubaev M.A., Bakhtiyarova K.Z.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(4): 159‑163

DOI: 10.17116/jnevro2024124041159

Views: 562

Downloaded: 4

Buy for 200₽
Contact the author
Table of contents

To cite this article:

Kuzmina USh, Tukhvatullin AV, Lyutov OV, et al. . A case of COVID-associated encephalopathy in a patient with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(4):159‑163. (In Russ.)
https://doi.org/10.17116/jnevro2024124041159

Подписка 2025 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Serum neurofilament light chains in asse­ssing the course of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(1):89-93
The effe­ctiveness of tele-rehabilitation for patients with multiple scle­rosis during the COVID-19 pandemic in 2020—2021 was evaluated in this study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):75-81
Long-term effi­cacy and safety of divo­zilimab during 2-year treatment of multiple scle­rosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):86-96
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42
Limi­tations and possibilities of treatment of patients with infe­rtility against the background of multiple scle­rosis disease during the COVID-19 pandemic. Russian Bulletin of Obstetrician-Gynecologist. 2024;(1):83-87
Vali­dation of e-version of Russian-language expa­nded disa­bility status scale (EDSS) for patients with multiple scle­rosis in the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2024;(1):9-16
Opti­cal cohe­rence tomo­graphy angiography in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(2):63-70
Opti­cal cohe­rence tomo­graphy in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(3):59-68

A case of acute encephalopathy manifested with impaired consciousness, hemichorrhea, speech and cognitive impairment in a female patient with COVID-19 and multiple sclerosis is presented. In the literature, there are isolated reports of such a combination of diseases, and therefore difficulties arise in carrying out differential diagnosis and prescribing therapy. Given the limited knowledge about the long-term consequences of COVID-19, systematic analysis of such cases and follow-up of such patients is necessary.

Keywords:

multiple sclerosis
COVID-associated encephalopathy

Authors:

Kuzmina U.Sh.

Bashkir State Medical University;
Institute of Biochemistry and Genetics — Subdivision of the Ufa Federal Research Center

Tukhvatullin A.V.

Institute of Biochemistry and Genetics — Subdivision of the Ufa Federal Research Center

Lyutov O.V.

Bashkir State Medical University

Talipova I.D.

Bashkir State Medical University

Zakirova E.N.

Bashkir State Medical University

Rakhmatullin A.R.

Bashkir State Medical University

Kutlubaev M.A.

Bashkir State Medical University

Bakhtiyarova K.Z.

Bashkir State Medical University

Received:

21.12.2023

Accepted:

23.12.2023

List of references:

  1. Dale L. Neurological Complications of COVID-19: A Review of the Literature. Cureus. 2022;14(8):e27633. https://doi.org/10.7759/cureus.27633
  2. Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020;38(7):1549.e3-1549.e7.  https://doi.org/10.1016/j.ajem.2020.05.024
  3. Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist. 2021;27(6):582-603.  https://doi.org/10.1177/1073858420956905
  4. Steardo L, Steardo L Jr, Zorec R, et al. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19. Acta Physiol (Oxf). 2020;229(3):e13473. https://doi.org/10.1111/apha.13473
  5. Sarıoğlu E, Yılmaz Sarıaltın S, Çoban T. Neurologıcal Complıcatıons and Potentıal Effects of Covıd-19: Symptoms and Conceıvable Mechanısms. Brain Hemorrhages. 2023 Feb 10.  https://doi.org/10.1016/j.hest.2023.02.001
  6. El Hajj T, Hassoun M, Harb R, et al. Neurological Manifestations of Coronavirus Disease 2019 in Hospitalized Patients: A Lebanese Cohort Study. Cureus. 2023;15(3):e35633. Published 2023 Mar 1.  https://doi.org/10.7759/cureus.35633
  7. Filatov A, Sharma P, Hindi F, et al. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus. 2020;12(3):e7352. https://doi.org/10.7759/cureus.7352
  8. Bellucci G, Rinaldi V, Buscarinu MC, et al. Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?. Front aImmunol. 2021;12:755333. https://doi.org/10.3389/fimmu.2021.755333
  9. Sepúlveda M, Llufriu S, Martínez-Hernández E, et al. Incidence and Impact of COVID-19 in MS: A Survey From a Barcelona MS Unit. Neurol Neuroimmunol Neuroinflamm. 2021;8(2):e954. https://doi.org/10.1212/NXI.0000000000000954
  10. Pugliatti M, Berger T, Hartung HP, et al. Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations. Curr Opin Neurol. 2022;35(3):319-327.  https://doi.org/10.1097/WCO.0000000000001066
  11. Fan M, Qiu W, Bu B, et al. Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders. Neurol Neuroimmunol Neuroinflamm. 2020;7(5):e787. https://doi.org/10.1212/NXI.0000000000000787
  12. Gusev EI, Martynov MY, Boyko AN, et al. The Novel Coronavirus Infection (COVID-19) and Nervous System Involvement: Mechanisms of Neurological Disorders, Clinical Manifestations, and the Organization of Neurological Care. Neurosci Behav Physiol. 2021;51(2):147-154.  https://doi.org/10.1007/s11055-021-01050-0
  13. Salter A, Fox RJ, Newsome SD, et al. Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis JAMA Neurol. 2021;78(6):699-708.  https://doi.org/10.1001/jamaneurol.2021.0688
  14. Freedman MS, Jack D, Murgašová Z, et al. Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis. Mult Scler Relat Disord. 2021;56:103283. https://doi.org/10.1016/j.msard.2021.103283
  15. Loonstra FC, Hoitsma E, van Kempen ZL, et al. COVID-19 in multiple sclerosis: The Dutch experience. Mult Scler. 2020;26(10):1256-1260. https://doi.org/10.1177/1352458520942198
  16. Evangelou N, Garjani A. Lymphocyte counts and the risk of COVID-19 in people with MS. Mult Scler. 2021;27(10):1625-1626. https://doi.org/10.1177/1352458520965460
  17. Bsteh G, Assar H, Hegen H, et al. COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry. PLoS One. 2021;16(7):e0255316. https://doi.org/10.1371/journal.pone.0255316
  18. Simpson-Yap S, De Brouwer E, Kalincik T, et al. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. Neurology. 2021;97(19):e1870-e1885. https://doi.org/10.1212/WNL.0000000000012753
  19. Naser Moghadasi A. Encephalopathy associated with COVID-19 in a patient with multiple sclerosis. J Neurovirol. 2020;26(6):973-975.  https://doi.org/10.1007/s13365-020-00921-5
  20. Hollen C, Bernard J. Multiple Sclerosis Management During the COVID-19 Pandemic. Curr Neurol Neurosci Rep. 2022;22(8):537-543.  https://doi.org/10.1007/s11910-022-01211-9
  21. Uginet M, Breville G, Assal F, et al. COVID-19 encephalopathy: Clinical and neurobiological features. J Med Virol. 2021;93(7):4374-4381. https://doi.org/10.1002/jmv.26973
  22. Kihira S, Delman BN, Belani P, et al. Imaging Features of Acute Encephalopathy in Patients with COVID-19: A Case Series. AJNR Am J Neuroradiol. 2020;41(10):1804-1808. https://doi.org/10.3174/ajnr.A6715
  23. Jain R, Young M, Dogra S, et al. COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome. J Neurol Sci. 2020;414:116923. https://doi.org/10.1016/j.jns.2020.116923
  24. Elmakaty I, Ferih K, Karen O, et al. Clinical Implications of COVID-19 Presence in CSF: Systematic Review of Case Reports. Cells. 2022;11(20):3212. https://doi.org/10.3390/cells11203212
  25. Fernandes de Souza WD, Fonseca DMD, Sartori A. COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels. Cells. 2023;12(5):684.  https://doi.org/10.3390/cells12050684

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register


We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.